|
1
|
Hariharan D, Saied A and Kocher HM:
Analysis of mortality rates for pancreatic cancer across the world.
HPB. 10:58–62. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society: Cancer Facts
& Figures 2012. American Cancer Society; Atlanta, GA, USA:
2012
|
|
3
|
Stat Fact Sheets SEER: Pancreas Cancer.
National Cancer Institute; 2013
|
|
4
|
Ishiwata T: Pancreatic ductal
adenocarcinoma: Basic and clinical challenges for better prognosis.
J Carcinog Mutagen. S9:2157–2518. 2013.http://dx.doi.org/4172/2157-2518.S9-005
|
|
5
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Partensky C: Toward a better understanding
of pancreatic ductal adenocarcinoma: Glimmers of hope? Pancreas.
42:729–739. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talamini R, Polesel J, Gallus S, Dal Maso
L, Zucchetto A, Negri E, Bosetti C, Lucenteforte E, Boz G,
Franceschi S, et al: Tobacco smoking, alcohol consumption and
pancreatic cancer risk: A case-control study in Italy. Eur J
Cancer. 46:370–376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gapstur SM, Jacobs EJ, Deka A, McCullough
ML, Patel AV and Thun MJ: Association of alcohol intake with
pancreatic cancer mortality in never smokers. Arch Intern Med.
171:444–451. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jandaghi P, Najafabadi HS, Bauer AS,
Papadakis AI, Fassan M, Hall A, Monast A, von Knebel Doeberitz M,
Neoptolemos JP, Costello E, et al: Expression of DRD2 is increased
in human pancreatic ductal adenocarcinoma and inhibitors slow tumor
growth in mice. Gastroenterology. 151:1218–1231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teodorczyk M, Kleber S, Wollny D, Sefrin
JP, Aykut B, Mateos A, Herhaus P, Sancho-Martinez I, Hill O,
Gieffers C, et al: CD95 promotes metastatic spread via Sck in
pancreatic ductal adenocarcinoma. Cell Death Differ. 22:1192–1202.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cote GA, Gore AJ, McElyea SD, Heathers LE,
Xu H, Sherman S and Korc M: A pilot study to develop a diagnostic
test for pancreatic ductal adenocarcinoma based on differential
expression of select miRNA in plasma and bile. Am J Gastroenterol.
109:1942–1952. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ye Y, Chen J, Zhou Y, Fu Z, Zhou Q, Wang
Y, Gao W, Zheng S, Zhao X, Chen T, et al: High expression of
AFAP1-AS1 is associated with poor survival and short-term
recurrence in pancreatic ductal adenocarcinoma. J Transl Med.
13:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Witkiewicz AK, McMillan EA, Balaji U, Baek
G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, et
al: Whole-exome sequencing of pancreatic cancer defines genetic
diversity and therapeutic targets. Nat Commun. 6:67442015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berger B, Peng J and Singh M:
Computational solutions for omics data. Nat Rev Genet. 14:333–346.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Donahue TR, Tran LM, Hill R, Li Y,
Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ,
et al: Integrative survival-based molecular profiling of human
pancreatic cancer. Clin Cancer Res. 18:1352–1363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kerr MK: Linear models for microarray data
analysis: Hidden similarities and differences. J Comput Biol.
10:891–901. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hadley W: ggplot2: Elegant Graphics for
Data Analysis. Springer; Switzerland: 2016
|
|
19
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation,
Visualization, and Integrated Discovery. Genome Biol. 4:32003.
View Article : Google Scholar
|
|
20
|
Acunzo M and Croce CM: MicroRNA in cancer
and cachexia - A mini-review. J Infect Dis. 212:(Suppl 1). S74–S77.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kutmon M, Kelder T, Mandaviya P, Evelo CT
and Coort SL: CyTargetLinker: A cytoscape app to integrate
regulatory interactions in network analysis. PLoS One.
8:e821602013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aguirre-Gamboa R, Gomez-Rueda H,
Martínez-Ledesma E, Martínez-Torteya A, Chacolla-Huaringa R,
Rodriguez-Barrientos A, Tamez-Peña JG and Treviño V: SurvExpress:
An online biomarker validation tool and database for cancer gene
expression data using survival analysis. PLoS One. 8:e742502013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mollenhauer J, Roether I and Kern HF:
Distribution of extracellular matrix proteins in pancreatic ductal
adenocarcinoma and its influence on tumor cell proliferation in
vitro. Pancreas. 2:14–24. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pandol S, Edderkaoui M, Gukovsky I, Lugea
A and Gukovskaya A: Desmoplasia of pancreatic ductal
adenocarcinoma. Clin Gastroenterol Hepatol. 7:(Suppl 11). S44–47.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mahadevan D and Von Hoff DD: Tumor-stroma
interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther.
6:1186–1197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Crowe DL and Ohannessian A: Recruitment of
focal adhesion kinase and paxillin to beta1 integrin promotes
cancer cell migration via mitogen activated protein kinase
activation. BMC Cancer. 4:182004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schmitz KJ, Grabellus F, Callies R,
Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW and
Baba HA: High expression of focal adhesion kinase
(p125FAK) in node-negative breast cancer is related to
overexpression of HER-2/neu and activated Akt kinase but does not
predict outcome. Breast Cancer Res. 7:R194–R203. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sawai H, Okada Y, Funahashi H, Matsuo Y,
Takahashi H, Takeyama H and Manabe T: Activation of focal adhesion
kinase enhances the adhesion and invasion of pancreatic cancer
cells via extracellular signal-regulated kinase-1/2 signaling
pathway activation. Mol Cancer. 4:372005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Muniyan S, Haridas D, Chugh S, Rachagani
S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP
and Batra SK: MUC16 contributes to the metastasis of pancreatic
ductal adenocarcinoma through focal adhesion mediated signaling
mechanism. Genes Cancer. 7:110–124. 2016.PubMed/NCBI
|
|
31
|
Mall AS: Analysis of mucins: Role in
laboratory diagnosis. J Clin Pathol. 61:1018–1024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saitou M, Goto M, Horinouchi M, Tamada S,
Nagata K, Hamada T, Osako M, Takao S, Batra SK, Aikou T, et al:
MUC4 expression is a novel prognostic factor in patients with
invasive ductal carcinoma of the pancreas. J Clin Pathol.
58:845–852. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu Y, Zhang JJ, Zhu R, Zhu Y, Liang WB,
Gao WT, Yu JB, Xu ZK and Miao Y: The increase in the expression and
hypomethylation of MUC4 gene with the progression of pancreatic
ductal adenocarcinoma. Med Oncol. 28:(Suppl 1). S175–S184. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jonckheere N, Skrypek N, Merlin J, Dessein
AF, Dumont P, Leteurtre E, Harris A, Desseyn JL, Susini C, Frénois
F, et al: The mucin MUC4 and its membrane partner ErbB2 regulate
biological properties of human CAPAN-2 pancreatic cancer cells via
different signalling pathways. PLoS One. 7:e322322012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goan YG, Zhou B, Hu E, Mi S and Yen Y:
Overexpression of ribonucleotide reductase as a mechanism of
resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell
line. Cancer Res. 59:4204–4207. 1999.PubMed/NCBI
|
|
36
|
Eriksson S and Martin DW Jr:
Ribonucleotide reductase in cultured mouse lymphoma cells. Cell
cycle-dependent variation in the activity of subunit protein M2. J
Biol Chem. 256:9436–9440. 1981.PubMed/NCBI
|
|
37
|
Duxbury MS, Ito H, Zinner MJ, Ashley SW
and Whang EE: RNA interference targeting the M2 subunit of
ribonucleotide reductase enhances pancreatic adenocarcinoma
chemosensitivity to gemcitabine. Oncogene. 23:1539–1548. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Duxbury MS and Whang EE: RRM2 induces
NF-kappaB-dependent MMP-9 activation and enhances cellular
invasiveness. Biochem Biophys Res Commun. 354:190–196. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Carr MW, Roth SJ, Luther E, Rose SS and
Springer TA: Monocyte chemoattractant protein 1 acts as a
T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 91:3652–3656.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Monti P, Leone BE, Marchesi F, Balzano G,
Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, et
al: The CC chemokine MCP-1/CCL2 in pancreatic cancer progression:
Regulation of expression and potential mechanisms of antimalignant
activity. Cancer Res. 63:7451–7461. 2003.PubMed/NCBI
|
|
41
|
Kalbasi A, Komar CA, Tooker GM, Liu M, Lee
JW, Gladney WL, Ben-Josef E and Beatty GL: Tumor-derived CCL2
mediates resistance to radiotherapy in pancreatic ductal
adenocarcinoma. Clin Cancer Res. 23:137–148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tan MC, Goedegebuure PS, Belt BA, Flaherty
B, Sankpal N, Gillanders WE, Eberlein TJ, Hsieh CS and Linehan DC:
Disruption of CCR5-dependent homing of regulatory T cells inhibits
tumor growth in a murine model of pancreatic cancer. J Immunol.
182:1746–1755. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang ML, Lu S, Zhou L and Zheng SS:
Correlation between ECT2 gene expression and methylation change of
ECT2 promoter region in pancreatic cancer. Hepatobiliary Pancreat
Dis Int. 7:533–538. 2008.PubMed/NCBI
|
|
44
|
Hrabar D, Aralica G, Gomercic M, Ljubicic
N, Kruslin B and Tomas D: Epithelial and stromal expression of
syndecan-2 in pancreatic carcinoma. Anticancer Res. 30:2749–2753.
2010.PubMed/NCBI
|
|
45
|
Lesina M, Kurkowski MU, Ludes K, Rose-John
S, Treiber M, Klöppel G, Yoshimura A, Reindl W, Sipos B, Akira S,
et al: Stat3/Socs3 activation by IL-6 transsignaling promotes
progression of pancreatic intraepithelial neoplasia and development
of pancreatic cancer. Cancer Cell. 19:456–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
